← Eichor
Study identifier: NCT06586840 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Effect of Adding an IPACK Block to the Adductor Canal Block on Total Knee Arthroplasty Surgery

Condition: Postoperative Pain, Acute  ·  Sponsor: Aydin Adnan Menderes University

PhaseN/A
Planned participants80
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersYes

About this study

Total knee arthroplasty (TKA) is a frequently performed major orthopedic surgery, where most patients experience severe postoperative pain. Pain-related delays in patient mobilization can lead to thromboembolism, deep vein thrombosis, surgical site infection, and increased risk of hospital-acquired infections due to prolonged hospital stay. Optimal postoperative knee analgesia is crucial not only for patient comfort and satisfaction but also for accelerating mobilization, functional recovery, and discharge from the hospital. To facilitate early ambulation and superior performance, multimodal analgesia and motor-sparing blocks are increasingly utilized

This description comes directly from the study's public registry record.

Talk to the study team

MURAT DEMİRCİOGLU  ·  +905393403222  ·  muratdemircioglu01@gmail.com

MUSTAFA OGURLU  ·  +905326056932  ·  mogurlu@adu.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Murat DemirciogluAydin, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06586840